Strategies for short hairpin RNA delivery in cancer gene therapy

Bibliography

• Caplen NJ. Gene therapy progress and prospects. Downregulating gene expression: the impact of RNA interference. Gene Ther 2004;11:1241-8
   PubMed Web of Science ®Google Scholar
• Fuchs U, Borkhardt A. The application of siRNA technology to cancer biology discovery. Adv Cancer Res 2007;96:75-102
   PubMed Web of Science ®Google Scholar
• Dykxhoorn DM, Lieberman J. The silent revolution: RNA interference as basic biology, research tool, and therapeutic. Annu Rev Med 2005;56:401-23
   PubMed Web of Science ®Google Scholar
• Folini M, Pennati M, Zaffaroni N. RNA interference-mediated validation of genes involved in telomere maintenance and evasion of apoptosis as cancer therapeutic targets. Methods Mol Biol 2009;487:303-30
   PubMedGoogle Scholar
• Micklem DR, Lorens JB. RNAi screening for therapeutic targets in human malignancies. Curr Pharm Biotechnol 2007;8:337-43
   PubMed Web of Science ®Google Scholar
• Sumimoto H, Kawakami Y. Lentiviral vector-mediated RNAi and its use for cancer research. Future Oncol 2007;3:655-64
   PubMedGoogle Scholar
• Haney SA. Expanding the repertoire of RNA interference screens for developing new anticancer drug targets. Expert Opin Ther Targets 2007;11:1429-41
   PubMed Web of Science ®Google Scholar
• Takeshita F, Ochiya T. Therapeutic potential of RNA interference against cancer. Cancer Sci 2006;97:689-96
   PubMed Web of Science ®Google Scholar
• Vorhies JS, Nemunaitis J. Nonviral delivery vehicles for use in short hairpin RNA-based cancer therapies. Expert Rev Anticancer Ther 2007;7:373-82
   PubMed Web of Science ®Google Scholar
• Azkur AK, Kim B, Suvas S, Blocking mouse MMP-9 production in tumor cells and mouse cornea by short hairpin (sh) RNA encoding plasmids. Oligonucleotides 2005;15:72-84
   PubMed Web of Science ®Google Scholar
• Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002;296:550-3
   PubMed Web of Science ®Google Scholar
• Martinez J, Patkaniowska A, Urlaub H, Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 2002;110:563-74
   PubMed Web of Science ®Google Scholar
• Khvorova A, Reynolds A, Jayasena SD. Functional siRNAs and miRNAs exhibit strand bias. Cell 2003;115:209-16
   PubMed Web of Science ®Google Scholar
• Schwarz DS, Hutvagner G, Haley B, Zamore PD. Evidence that siRNAs function as guides, not primers, in the drosophila and human RNAi pathways. Mol Cell 2002;10:537-48
   PubMed Web of Science ®Google Scholar
• Elbashir SM, Harborth J, Lendeckel W, Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001;411:494-8
   PubMed Web of Science ®Google Scholar
• Lee NS, Dohjima T, Bauer G, Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol 2002;20:500-5
   PubMed Web of Science ®Google Scholar
• Paul CP, Good PD, Winer I, Engelke DR. Effective expression of small interfering RNA in human cells. Nat Biotechnol 2002;20:505-8
   PubMed Web of Science ®Google Scholar
• Brummelkamp TR, Bernards R, Agami R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2002;2:243-7
   PubMed Web of Science ®Google Scholar
• Omi K, Tokunaga K, Hohjoh H. Long-lasting RNAi activity in mammalian neurons. FEBS Lett 2004;558:89-95
   PubMed Web of Science ®Google Scholar
• Harborth J, Elbashir SM, Vandenburgh K, Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. Antisense Nucleic Acid Drug Dev 2003;13:83-105
   PubMedGoogle Scholar
• Paddison PJ, Caudy AA, Bernstein E, Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 2002;16:948-58
   PubMed Web of Science ®Google Scholar
• Miyagishi M, Taira K. Strategies for generation of an siRNA expression library directed against the human genome. Oligonucleotides 2003;13:325-33
   PubMed Web of Science ®Google Scholar
• Siolas D, Lerner C, Burchard J, Synthetic shRNAs as potent RNAi triggers. Nat Biotechnol 2005;23:227-31
   PubMed Web of Science ®Google Scholar
• Xu J, Li L, Hong J, Huang W. Effects of small interference RNA against PTP1B and TCPTP on insulin signaling pathway in mouse liver: evidence for non-synergetic cooperation. Cell Biol Int 2007;31:88-91
   PubMed Web of Science ®Google Scholar
• Behlke MA. Progress towards in vivo use of siRNAs. Mol Ther 2006;13:644-70
   PubMed Web of Science ®Google Scholar
• Wolff JA, Budker V. The mechanism of naked DNA uptake and expression. Adv Genet 2005;54:3-20
   PubMed Web of Science ®Google Scholar
• DiFiglia M, Sena-Esteves M, Chase K, Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits. Proc Natl Acad Sci USA 2007;104:17204-9
   PubMed Web of Science ®Google Scholar
• de Fougerolles A, Novobrantseva T. siRNA and the lung: research tool or therapeutic drug? Curr Opin Pharmacol 2008;8:280-5
   PubMed Web of Science ®Google Scholar
• Nishikawa M, Huang L. Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum Gene Ther 2001;12:861-70
   PubMed Web of Science ®Google Scholar
• Li CX, Parker A, Menocal E, Delivery of RNA interference. Cell Cycle 2006;5:2103-9
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Yamaoka K, Nishikawa M, Takakura Y. Quantitative and temporal analysis of gene silencing in tumor cells induced by small interfering RNA or short hairpin RNA expressed from plasmid vectors. J Pharm Sci 2009;98:74-80
   PubMed Web of Science ®Google Scholar
• Lage H. Potential applications of RNA interference technology in the treatment of cancer. Future Oncol 2005;1:103-13
   PubMedGoogle Scholar
• Grimm D, Streetz KL, Jopling CL, Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 2006;441:537-41
   PubMed Web of Science ®Google Scholar
• Denti MA, Rosa A, Sthandier O, A new vector, based on the PolII promoter of the U1 snRNA gene, for the expression of siRNAs in mammalian cells. Mol Ther 2004;10:191-9
   Google Scholar
• Giering JC, Grimm D, Storm TA, Kay MA. Expression of shRNA from a tissue-specific pol II promoter is an effective and safe RNAi therapeutic. Mol Ther 2008;16:1630-6
   PubMed Web of Science ®Google Scholar
• Xing Y, Liu M, Du Y, Tumor cell-specific blockade of CXCR4/SDF-1 interactions in prostate cancer cells by hTERT promoter induced CXCR4 knockdown: a possible metastasis preventing and minimizing approach. Cancer Biol Ther 2008;7:1839-48
   PubMed Web of Science ®Google Scholar
• Zhao W, Xu Y, Kong D, Tissue-selective RNA interference in prostate cancer cell using prostate specific membrane antigen promoter/enhancer. Urol Oncol 2008:27:539-47
   PubMed Web of Science ®Google Scholar
• Hassani Z, Francois JC, Alfama G, A hybrid CMV-H1 construct improves efficiency of PEI-delivered shRNA in the mouse brain. Nucleic Acids Res 2007;35:e65. Published online 27 February 2007, doi:10.1093/nar/gkm152
   PubMed Web of Science ®Google Scholar
• Li L, Lin X, Khvorova A, Defining the optimal parameters for hairpin-based knockdown constructs. RNA 2007;13:1765-74
   PubMed Web of Science ®Google Scholar
• Rossi JJ. Expression strategies for short hairpin RNA interference triggers. Hum Gene Ther 2008;19:313-7
   PubMed Web of Science ®Google Scholar
• Scherer LJ, Frank R, Rossi JJ. Optimization and characterization of tRNA–shRNA expression constructs. Nucleic Acids Res 2007;35:2620-8
   PubMed Web of Science ®Google Scholar
• Sun D, Melegari M, Sridhar S, Multi-miRNA hairpin method that improves gene knockdown efficiency and provides linked multi-gene knockdown. Biotechniques 2006;41:59-63
   PubMed Web of Science ®Google Scholar
• Zhou H, Huang C, Xia XG. A tightly regulated Pol III promoter for synthesis of miRNA genes in tandem. Biochim Biophys Acta 2008;1779:773-9
   PubMed Web of Science ®Google Scholar
• Boden D, Pusch O, Lee F, Promoter choice affects the potency of HIV-1 specific RNA interference. Nucleic Acids Res 2003;31:5033-8
   PubMed Web of Science ®Google Scholar
• Hacein-Bey-Abina S, Von Kalle C, Schmidt M, LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003;302:415-9
   PubMed Web of Science ®Google Scholar
• Lufino MM, Edser PA, Wade-Martins R. Advances in high-capacity extrachromosomal vector technology: episomal maintenance, vector delivery, and transgene expression. Mol Ther 2008;16:1525-38
   PubMed Web of Science ®Google Scholar
• Kuhn R, Streif S, Wurst W. RNA interference in mice. Handb Exp Pharmacol 2007:149-76
   PubMedGoogle Scholar
• Singer O, Verma IM. Applications of lentiviral vectors for shRNA delivery and transgenesis. Curr Gene Ther 2008;8:483-8
   PubMed Web of Science ®Google Scholar
• Grimm D, Pandey K, Kay MA. Adeno-associated virus vectors for short hairpin RNA expression. Methods Enzymol 2005;392:381-405
   PubMed Web of Science ®Google Scholar
• Yoo JY, Kim JH, Kwon YG, VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth. Mol Ther 2007;15:295-302
   PubMed Web of Science ®Google Scholar
• Kaszubiak A, Holm PS, Lage H. Overcoming the classical multidrug resistance phenotype by adenoviral delivery of anti-MDR1 short hairpin RNAs and ribozymes. Int J Oncol 2007;31:419-30
   PubMed Web of Science ®Google Scholar
• Pan Q, Liu B, Liu J, Synergistic antitumor activity of XIAP-shRNA and TRAIL expressed by oncolytic adenoviruses in experimental HCC. Acta Oncol 2008;47:135-44
   PubMed Web of Science ®Google Scholar
• Zheng JN, Pei DS, Sun FH, Inhibition of renal cancer cell growth by oncolytic adenovirus armed short hairpin RNA targeting hTERT gene. Cancer Biol Ther 2009;8:84-91
   PubMed Web of Science ®Google Scholar
• Lee YJ, Imsumran A, Park MY, Adenovirus expressing shRNA to IGF-1R enhances the chemosensitivity of lung cancer cell lines by blocking IGF-1 pathway. Lung Cancer 2007;55:279-86
   PubMed Web of Science ®Google Scholar
• Bousarghin L, Touze A, Gaud G, Inhibition of cervical cancer cell growth by human papillomavirus virus-like particles packaged with human papillomavirus oncoprotein short hairpin RNAs. Mol Cancer Ther 2009;8:357-65
   PubMed Web of Science ®Google Scholar
• Rampias T, Sasaki C, Weinberger P, Psyrri A. E6 and E7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells. J Natl Cancer Inst 2009;101:412-23
   PubMed Web of Science ®Google Scholar
• Chen Y, Lin MC, Yao H, Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin. Hepatology 2007;46:200-8
   PubMed Web of Science ®Google Scholar
• Donsante A, Miller DG, Li Y, AAV vector integration sites in mouse hepatocellular carcinoma. Science 2007;317:477
   PubMed Web of Science ®Google Scholar
• Green JJ, Langer R, Anderson DG. A combinatorial polymer library approach yields insight into nonviral gene delivery. Acc Chem Res 2008;41:749-59
   PubMed Web of Science ®Google Scholar
• Gao X, Kim KS, Liu D. Nonviral gene delivery: what we know and what is next. AAPS J 2007;9:E92-104
   PubMed Web of Science ®Google Scholar
• Vorhies JS, Nemunaitis JJ. Synthetic vs. natural/biodegradable polymers for delivery of shRNA-based cancer therapies. Methods Mol Biol 2009;480:11-29
   PubMedGoogle Scholar
• Khalil IA, Kogure K, Akita H, Harashima H. Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacol Rev 2006;58:32-45
   PubMed Web of Science ®Google Scholar
• Wagstaff KM, Jans DA. Nucleocytoplasmic transport of DNA: enhancing non-viral gene transfer. Biochem J 2007;406:185-202
   PubMed Web of Science ®Google Scholar
• Eguchi A, Furusawa H, Yamamoto A, Optimization of nuclear localization signal for nuclear transport of DNA-encapsulating particles. J Control Release 2005;104:507-19
   PubMed Web of Science ®Google Scholar
• Lechardeur D, Lukacs GL. Nucleocytoplasmic transport of plasmid DNA: a perilous journey from the cytoplasm to the nucleus. Hum Gene Ther 2006;17:882-9
   PubMed Web of Science ®Google Scholar
• Greish K. Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines. J Drug Target 2007;15:457-64
   PubMed Web of Science ®Google Scholar
• Haley B, Frenkel E. Nanoparticles for drug delivery in cancer treatment. Urol Oncol 2008;26:57-64
   PubMed Web of Science ®Google Scholar
• Zamecnik J, Vargova L, Homola A, Extracellular matrix glycoproteins and diffusion barriers in human astrocytic tumours. Neuropathol Appl Neurobiol 2004;30:338-50
   PubMed Web of Science ®Google Scholar
• Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 2008;5:505-15
   PubMed Web of Science ®Google Scholar
• Jiang G, Li J, Zeng Z, Xian L. Lentivirus-mediated gene therapy by suppressing survivin in BALB/c nude mice bearing oral squamous cell carcinoma. Cancer Biol Ther 2006;5:435-40
   PubMed Web of Science ®Google Scholar
• Xia G, Kumar SR, Masood R, EphB4 expression and biological significance in prostate cancer. Cancer Res 2005;65:4623-32
   PubMed Web of Science ®Google Scholar
• Ito T, Hashimoto Y, Tanaka E, An inducible short-hairpin RNA vector against osteopontin reduces metastatic potential of human esophageal squamous cell carcinoma in vitro and in vivo. Clin Cancer Res 2006;12:1308-16
   PubMed Web of Science ®Google Scholar
• Zhang S, Zhao B, Jiang H, Cationic lipids and polymers mediated vectors for delivery of siRNA. J Control Release 2007;123:1-10
   PubMed Web of Science ®Google Scholar
• Tseng YC, Mozumdar S, Huang L. Lipid-based systemic delivery of siRNA. Adv Drug Deliv Rev 2009;61:721-31
   PubMed Web of Science ®Google Scholar
• Pardridge WM. shRNA and siRNA delivery to the brain. Adv Drug Deliv Rev 2007;59:141-52
   PubMed Web of Science ®Google Scholar
• Nagasaki T, Myohoji T, Tachibana T, Can nuclear localization signals enhance nuclear localization of plasmid DNA? Bioconjug Chem 2003;14:282-6
   PubMed Web of Science ®Google Scholar
• Pardridge WM. Intravenous, non-viral RNAi gene therapy of brain cancer. Expert Opin Biol Ther 2004;4:1103-13
   PubMed Web of Science ®Google Scholar
• Wagner E, Kircheis R, Walker GF. Targeted nucleic acid delivery into tumors: new avenues for cancer therapy. Biomed Pharmacother 2004;58:152-61
   PubMed Web of Science ®Google Scholar
• Spankuch B, Matthess Y, Knecht R, Cancer inhibition in nude mice after systemic application of U6 promoter-driven short hairpin RNAs against PLK1. J Natl Cancer Inst 2004;96:862-72
   PubMed Web of Science ®Google Scholar
• Gondi CS, Lakka SS, Dinh DH, RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas. Oncogene 2004;23:8486-96
   PubMed Web of Science ®Google Scholar
• Dass CR, Choong PF. Selective gene delivery for cancer therapy using cationic liposomes: in vivo proof of applicability. J Control Release 2006;113:155-63
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang YF, Bryant J, Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer. Clin Cancer Res 2004;10:3667-77
   PubMed Web of Science ®Google Scholar
• Chen Z, Liang K, Liu J, Enhancement of survivin gene downregulation and cell apoptosis by a novel combination: liposome microbubbles and ultrasound exposure. Med Oncol 2009; published online 7 January 2009, doi: 10.1007/s12032-008-9161-0
   Web of Science ®Google Scholar
• Moghimi SM, Symonds P, Murray JC, A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. Mol Ther 2005;11:990-5
   PubMed Web of Science ®Google Scholar
• Wightman L, Kircheis R, Rossler V, Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J Gene Med 2001;3:362-72
   PubMed Web of Science ®Google Scholar
• Fang L, Hu QG, Hua ZC, Li SF. Construction of targeting-Skp2 shRNA plasmids and observation of their inhibitory effect on Tca8113 cells. Zhonghua Kou Qiang Yi Xue Za Zhi 2007;42:624-8
   PubMedGoogle Scholar
• Lee MK, Chun SK, Choi WJ, The use of chitosan as a condensing agent to enhance emulsion-mediated gene transfer. Biomaterials 2005;26:2147-56
   PubMed Web of Science ®Google Scholar
• Katas H, Alpar HO. Development and characterisation of chitosan nanoparticles for siRNA delivery. J Control Release 2006;115:216-25
   PubMed Web of Science ®Google Scholar
• Liu X, Howard KA, Dong M, The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing. Biomaterials 2007;28:1280-8
   PubMed Web of Science ®Google Scholar
• de Martimprey H, Bertrand JR, Fusco A, siRNA nanoformulation against the ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma. Nucleic Acids Res 2008;36:e2. Published online 13 December 2007, doi:10.1093/nar/gkm1094
   PubMedGoogle Scholar
• Wang SL, Yao HH, Guo LL, Selection of optimal sites for TGFB1 gene silencing by chitosan-TPP nanoparticle-mediated delivery of shRNA. Cancer Genet Cytogenet 2009;190:8-14
   PubMed Web of Science ®Google Scholar
• Jere D, Xu CX, Arote R, Poly(beta-amino ester) as a carrier for si/shRNA delivery in lung cancer cells. Biomaterials 2008;29:2535-47
   PubMed Web of Science ®Google Scholar
• van der Aa MA, Mastrobattista E, Oosting RS, The nuclear pore complex: the gateway to successful nonviral gene delivery. Pharm Res 2006;23:447-59
   PubMed Web of Science ®Google Scholar
• Nagasaki T, Kawazu T, Tachibana T, Enhanced nuclear import and transfection efficiency of plasmid DNA using streptavidin-fused importin-beta. J Control Release 2005;103:199-207
   PubMed Web of Science ®Google Scholar
• Liu Y, Tao J, Li Y, Targeting hypoxia-inducible factor-1alpha with Tf-PEI-shRNA complex via transferrin receptor-mediated endocytosis inhibits melanoma growth. Mol Ther 2009;17:269-77
   PubMed Web of Science ®Google Scholar
• Misra S, Hascall VC, De Giovanni C, Delivery of CD44 shRNA/nanoparticles within cancer cells: perturbation of hyaluronan/CD44v6 interactions and reduction in adenoma growth in Apc Min/+ mice. J Biol Chem 2009;284:12432-46
   PubMed Web of Science ®Google Scholar
• Xu DQ, Zhang L, Kopecko DJ, Bacterial delivery of siRNAs: a new approach to solid tumor therapy. Methods Mol Biol 2009;487:161-87
   PubMedGoogle Scholar
• Uren AG, Kool J, Berns A, van Lohuizen M. Retroviral insertional mutagenesis: past, present and future. Oncogene 2005;24:7656-72
   PubMed Web of Science ®Google Scholar
• Collier LS, Carlson CM, Ravimohan S, Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse. Nature 2005;436:272-6
   PubMed Web of Science ®Google Scholar
• Rahrmann EP, Collier LS, Knutson TP, Identification of PDE4D as a proliferation promoting factor in prostate cancer using a sleeping beauty transposon-based somatic mutagenesis screen. Cancer Res 2009;69:4388-97
   PubMed Web of Science ®Google Scholar
• Whitehead KA, Langer R, Anderson DG. Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov 2009;8:129-38
   PubMed Web of Science ®Google Scholar